CNS Pharmaceuticals CNSP
$ 0.13
2.72%
Quarterly report 2024-Q3
added 11-14-2024
CNS Pharmaceuticals EV/EBITDA Ratio 2011-2024 | CNSP
Annual EV/EBITDA Ratio CNS Pharmaceuticals
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
0.205 | -1.56 | -13.6 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
0.205 | -13.6 | -4.99 |